WHO WHAT WHEN WHY Nuwellis, Inc. Termination of the REVERSE-HF clinical trial July 17, 2025 To redirect resources toward outpatient markets where scalable impact is highest. MINNEAPOLIS, July 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. today announced the termination of its REVERSE-HF clinical trial, a randomized post-market trial evaluating ultrafiltration vs. IV loop diuretic therapy for fluid management in hospitalized... Read More